Literature DB >> 10077665

Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein.

A O Gramolini1, L M Angus, L Schaeffer, E A Burton, J M Tinsley, K E Davies, J P Changeux, B J Jasmin.   

Abstract

The modulation of utrophin gene expression in muscle by the nerve-derived factor agrin plausibly involves the trophic factor ARIA/heregulin. Here we show that heregulin treatment of mouse and human cultured myotubes caused a approximately 2.5-fold increase in utrophin mRNA levels. Transient transfection experiments with utrophin promoter-reporter gene constructs showed that this increase resulted from an enhanced transcription of the utrophin gene. In the case of the nicotinic acetylcholine receptor delta and epsilon subunit genes, heregulin was previously reported to stimulate transcription via a conserved promoter element, the N-box, which binds the multimeric Ets-related transcription factor GA binding protein (GABP). Accordingly, site-directed mutagenesis of a single N-box motif in the utrophin gene promoter abolished the transcriptional response to heregulin. In addition, overexpression of heregulin, or of the two GABP subunits in cultured myotubes, caused an N-box-dependent increase of the utrophin promoter activity. In vivo, direct gene transfer into muscle confirmed that heregulin regulates utrophin gene expression. Finally, electrophoretic mobility shift assays and supershift experiments performed with muscle extracts revealed that the N-box of the utrophin promoter binds GABP. These findings suggest that the subsynaptic activation of transcription by heregulin via the N-box motif and GABP are conserved among genes expressed at the neuromuscular junction. Because utrophin can functionally compensate for the lack of dystrophin, the elucidation of the molecular mechanisms regulating utrophin gene transcription may ultimately lead to therapies based on utrophin expression throughout the muscle fibers of Duchenne muscular dystrophy patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077665      PMCID: PMC15923          DOI: 10.1073/pnas.96.6.3223

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Increased expression of dystrophin, beta-dystroglycan and adhalin in denervated rat muscles.

Authors:  D Biral; L Senter; G Salviati
Journal:  J Muscle Res Cell Motil       Date:  1996-10       Impact factor: 2.698

Review 2.  Dystrophin and its isoforms.

Authors:  H M Sadoulet-Puccio; L M Kunkel
Journal:  Brain Pathol       Date:  1996-01       Impact factor: 6.508

3.  [Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].

Authors:  M Fardeau; F M Tomé; H Collin; N Augier; F Pons; J Léger; J Léger
Journal:  C R Acad Sci III       Date:  1990

4.  An autosomal transcript in skeletal muscle with homology to dystrophin.

Authors:  D R Love; D F Hill; G Dickson; N K Spurr; B C Byth; R F Marsden; F S Walsh; Y H Edwards; K E Davies
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

5.  Expression of full-length utrophin prevents muscular dystrophy in mdx mice.

Authors:  J Tinsley; N Deconinck; R Fisher; D Kahn; S Phelps; J M Gillis; K Davies
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

6.  Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle.

Authors:  K Ohlendieck; J M Ervasti; K Matsumura; S D Kahl; C J Leveille; K P Campbell
Journal:  Neuron       Date:  1991-09       Impact factor: 17.173

7.  Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines.

Authors:  T M Nguyen; J M Ellis; D R Love; K E Davies; K C Gatter; G Dickson; G E Morris
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

8.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle.

Authors:  K Matsumura; J M Ervasti; K Ohlendieck; S D Kahl; K P Campbell
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

Review 9.  Population frequencies of inherited neuromuscular diseases--a world survey.

Authors:  A E Emery
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

10.  Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle.

Authors:  T S Khurana; S C Watkins; P Chafey; J Chelly; F M Tomé; M Fardeau; J C Kaplan; L M Kunkel
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

View more
  30 in total

1.  Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP-dependent protein kinase.

Authors:  S Barradeau; T Imaizumi-Scherrer; M C Weiss; D M Faust
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.

Authors:  A Briguet; M A Ruegg
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Sodium channel mRNAs at the neuromuscular junction: distinct patterns of accumulation and effects of muscle activity.

Authors:  S S Awad; R N Lightowlers; C Young; Z M Chrzanowska-Lightowlers; T Lomo; C R Slater
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

4.  Identification of a crucial site for synoviolin expression.

Authors:  Kaneyuki Tsuchimochi; Naoko Yagishita; Satoshi Yamasaki; Tetsuya Amano; Yukihiro Kato; Ko-ichi Kawahara; Satoko Aratani; Hidetoshi Fujita; Fengyun Ji; Akiko Sugiura; Toshihiko Izumi; Asako Sugamiya; Ikuro Maruyama; Akiyoshi Fukamizu; Setsuro Komiya; Kusuki Nishioka; Toshihiro Nakajima
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Postsynaptic chromatin is under neural control at the neuromuscular junction.

Authors:  Aymeric Ravel-Chapuis; Marie Vandromme; Jean-Luc Thomas; Laurent Schaeffer
Journal:  EMBO J       Date:  2007-02-15       Impact factor: 11.598

6.  The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.

Authors:  K J Perkins; E A Burton; K E Davies
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

7.  Regulation of the Hsp90-binding immunophilin, cyclophilin 40, is mediated by multiple sites for GA-binding protein (GABP).

Authors:  P Kumar; B K Ward; R F Minchin; T Ratajczak
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

Review 8.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

9.  Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function.

Authors:  Yifan Lu; Chai Tian; Gawiyou Danialou; Rénald Gilbert; Basil J Petrof; George Karpati; Josephine Nalbantoglu
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

10.  Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle.

Authors:  Christian Jacobson; David Duggan; Gerald Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.